-
2024-511879-16-00
5
2024-12-12
Prurigo Nodularis
-
2023-504751-28-00
5
2024-09-24
Exudative age-related macular degeneration
-
2023-504445-31-00
4
2024-09-19
Carcinoma, Head and Neck
-
2023-507402-13-00
5
2024-04-03
Multiple myeloma
-
2022-501606-35-01
11
2024-02-21
Platinum-sensitive epithelial ovarian, fallopian tube, or primary
peri
-
2022-501980-42-00
5
2023-12-21
Anemia associated with Chronic Kidney Disease
-
2022-502061-17-00
6
2023-12-15
Haemophilia A
-
2024-515830-34-00
5
2023-02-14
Congenital antithrombin deficiency
-
2022-502503-30-00
5
2022-12-15
Acute lymphoblastic leukemia
-
2023-507518-28-00
5
2022-09-13
Acute myeloid leukemia
-
2024-512259-19-00
4
2021-04-08
Primary Hyperoxaluria
-
2024-512657-24-00
10
2014-03-27
Acute Lymphoblastic Leukaemia
-
2025-524580-21-00
10
2026-06-01
Grass pollen induced allergic rhinitis or rhinoconjunctivitis
-
2025-523543-36-00
11
2026-05-18
pediatric emergence delirium
-
2025-523938-10-00
5
2026-05-05
Diabetic Macular Edema (DME)
-
2025-523914-10-00
6
2026-04-30
Critical illness
-
2025-522567-15-00
5
2026-04-28
Plaque Psoriasis
-
2024-513174-22-00
4
2026-04-14
Atrophic Age-related Macular Degeneration (AMD)
-
2025-521012-18-00
5
2026-04-13
Facioscapulohumeral Muscular Dystrophy (FSHD)
-
2025-523085-24-00
5
2026-04-13
Biliary Tract Cancer
-
2025-523119-12-00
10
2026-04-02
Patients with moderate-to-severe allergic rhinitis / rhinoconjunctivit
-
2024-520101-39-00
5
2026-04-01
TROP2 NMR-positive advanced or metastatic non-squamous non-small cell
-
2024-516544-26-00
4
2026-03-30
acute ischemic stroke
-
2024-518210-81-00
5
2026-03-18
Advanced Hepatocellular Carcinoma